Alnylam Pharmaceuticals
ALNY
#700
Rank
A$52.67 B
Marketcap
A$394.51
Share price
-2.98%
Change (1 day)
-16.81%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company